PhD, Social Medicine and Health Management                                         2013-2018

School of Public Health, School of Medicine, Zhejiang University, China

Experience:

Visiting Scholar in Department of Global Health Management and Policy, School of Public Health and Tropical Medicine, Tulane University, USA (2017.08-2018.09)

Shuyan Gu, Xiaoyong Wang et al. (2017). Cost-Effectiveness of Exenatide Twice Daily vs Insulin Glargine as Add-on Therapy to Oral Antidiabetic Agents in Patients with Type 2 Diabetes in China. Diabetes Obes Metab. 19(12):1688-97.

Shuyan Gu, Yiming Mu, et al. (2016). Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China. PLoS One. 2016;11(11).

Shuyan Gu, Huimei Hu & Hengjin Dong. (2016). Systematic Review of the Economic Burden of Pulmonary Arterial Hypertension. PharmacoEconomics. 34(6):533-50.

Shuyan Gu, Yuhang Zeng, et al. (2016). Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China. PLoS One. 11(11).

Shuyan Gu, Huimei Hu & Hengjin Dong. (2016). Systematic Review of Health-Related Quality of Life in Patients with Pulmonary Arterial Hypertension. PharmacoEconomics. 34(8):751-70.

Shuyan Gu, Jing Deng, et al. (2015). Cost-Effectiveness of Saxagliptin vs Glimepiride as a Second-Line Therapy Added to Metformin in Type 2 Diabetes in China. J Med Econ. 18(10):808-20.

Shuyan Gu, Jihao Shi et al. (2015). Comparison of Glucose Lowering Effect of Metformin and Acarbose in Type 2 Diabetes Mellitus: a Meta-Analysis. PLoS One. 2015;10(5).

Shuyan Gu, Zhiliu Tang, et al. (2015). Cost-Minimization Analysis of Metformin and Acarbose in Treatment of Type 2 Diabetes. Value Health Reg Issues. 6:84-8.

   2018, International Society for Pharmacoeconomics and Outcomes Research 23^rd Annual International Meeting, USA, a poster presentation (first author).

   2017, The International Doctoral Student Conference, China, an oral presentation (first author).

   2016, International Society for Pharmacoeconomics and Outcomes Research 7^th Asia-Pacific Conference, Singapore, two poster presentations (first author).

   2016, Chinese Economists Society Annual Conference, China, an oral presentation (first author).

   2016, Health Technology Assessment International 2016 Annual Meeting, two oral presentation (first author).

   2015, Symposium on Social Determinants of Health, India, an oral presentation (first author).

   2015, 12^th Health Technology Assessment International Annual Meeting, Norway, a poster presentation (first author).

   2014, International Society for Pharmacoeconomics and Outcomes Research 6^th Asia-Pacific Conference, China, a poster presentation (first author).